Robin Wolz
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study.
Journal: Alzheimer's research & therapy
Published: February 05, 2026
Cortical gray-white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 29, 2026
Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography: Results from Bio-Hermes Study participants.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 12, 2025
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: August 14, 2025
Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: March 28, 2025
Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia.
Journal: Neurology
Published: September 17, 2024
Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity.
Journal: Neurology
Published: June 11, 2024
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 22, 2024
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure.
Journal: Annals of clinical and translational neurology
Published: March 18, 2024
Amyloid-PET imaging predicts functional decline in clinically normal individuals.
Journal: Alzheimer's research & therapy
Published: February 01, 2024
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 31, 2023
Last Updated: 09/26/2026